PATHWAY BIOPHARMA LIMITED

Company number SC677513 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

PATHWAY BIOPHARMA LIMITED - Analysis Report

Company Number: SC677513

Analysis Date: 2025-07-29 20:22 UTC

  1. Risk Rating: LOW
    The company demonstrates a stable net asset position with positive working capital across the last reported years. There are no overdue filings or indications of regulatory non-compliance. The business appears solvent with sufficient current assets to cover liabilities, suggesting low immediate financial risk.

  2. Key Concerns:

  • Declining net assets and net current assets over the last two years may indicate gradual erosion of equity and working capital, warranting monitoring.
  • Very small scale operations (micro-entity status and only 2 employees) may limit operational resilience and growth potential.
  • Lack of audit and limited financial disclosures restrict visibility into detailed financial performance and risks.
  1. Positive Indicators:
  • Current liabilities are well covered by current assets, with net current assets remaining positive (£36k in 2024).
  • No overdue statutory filings and timely submission of accounts and confirmation statements indicate good governance compliance.
  • Ownership and control are consolidated under a single experienced director, simplifying decision-making and accountability.
  • The company has maintained positive net assets throughout its history, evidencing solvency.
  1. Due Diligence Notes:
  • Investigate reasons behind the declining net assets and net current assets from 2022 to 2024 to assess whether this trend could continue.
  • Review the company’s revenue streams, profitability, and cash flow statements if available, since micro-entity accounts omit profit and loss details.
  • Confirm the director’s capacity and plans for business growth or risk mitigation given the small employee base and limited capital.
  • Verify that there are no contingent liabilities or off-balance sheet obligations not captured in the micro-entity accounts.
  • Assess the company’s client base, contracts, and market position within management consultancy to gauge operational sustainability.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.